Lv1
40 积分 2024-12-15 加入
Clinical toxicity of daridorexant: a retrospective analysis of poison centre data
14天前
已完结
Trends in anti-insomnia medication utilization among pediatric patients in nine cities in China: A real-world study (2016–2023)
2个月前
已完结
Efficacy and safety of daridorexant in Chinese patients with insomnia disorder: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial
2个月前
已关闭
Clinical practice guidelines for switching or deprescribing hypnotic medications for chronic insomnia: results of European neuropsychopharmacology and sleep expert’s consensus group
6个月前
已完结
Early experience with the new DORA daridorexant in patients with insomnia disorder and comorbid mental disturbances: Results of a naturalistic study with 3 months follow‐up
7个月前
已完结
Efficacy and Safety of Daridorexant in Chinese Patients with Insomnia Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial
7个月前
已完结
Daridorexant and Insomnia in Clinical Practice: A Nominal Group Technique Consensus Study among Italian Sleep and Insomnia Experts
7个月前
已完结
Treatment strategy for insomnia disorder: Japanese expert consensus
8个月前
已完结
Repeated dosing (5 nights) of 50 mg daridorexant in patients with severe obstructive sleep apnea: effect on sleep-disordered breathing and sleep
8个月前
已完结
Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials
8个月前
已完结
皖公网安备34019202002308
